 This version of the release contains a corrected hyperlink. RALEIGH, NC ACCESSWIRE May 19, 2021 9 Meters Biopharma, Inc. NASDAQ:NMTR, a clinical-stage company focused on rare and unmet needs in gastroenterology, today announced that the Companys CEO, John Temperato will present a corporate update at Oppenheimers Rare Orphan Disease Summit and invites investors to participate via webcast and in one-on-one meetings. 